70.10.Z - Head office activities
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
49 - Land transport and transport via pipelines
52 - Warehousing, storage, and support activities for transport
70 - Head office activities and management consultancy
73 - Advertising, market research and public relations
77 - Rental and leasing
45
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -3,8 | -3,8 | -4,2 | -9,7 |
EBITDA | -3,8 | -3,8 | -4,2 | -9,7 |
Short time liabilities | 20 | 20 | 10 | -50 |
Equity capital | -20,2 | -24 | -28,2 | -17,4 |
Operating profit (EBIT) | -3,8 | -3,8 | -4,2 | -9,7 |
Assets | 9,8 | 6 | 6,8 | 13,6 |
Net profit (loss) | -3,8 | -3,8 | -4,2 | -9,7 |
Cash | 6,8 | 3 | 4,8 | 60,4 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 30 | 30 | 35 | 16,7 |
Working assets | 6,8 | 3 | 4,8 | 60,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 18,9 | 15,9 | 14,8 | -1,1 |
Equity capital to total assets | -205,4 | -399,1 | -412,5 | -13,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.3411850035190582 | 0.1505350023508072 | 0.4828700125217438 | 0,3 |
Net dept to EBITDA | -3.455625534057617 | -4.455625534057617 | -7.21456241607666 | -2,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane